Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-20-024943

Director sold 22,845 shares at an average $85.36 ($1,949,996)

  • Director disposed of 207,408 shares (other)
  • Director acquired 49,663 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2020-09-09 Other disposition −164,162 2,074,817 I
Bolzon Bradley J PhD Director 2020-09-09 Other disposition −974 12,303 I
Bolzon Bradley J PhD Director 2020-09-09 Other acquisition +42,272 42,272 I
Bolzon Bradley J PhD Director 2020-09-09 Other disposition −42,272 0 I
Bolzon Bradley J PhD Director 2020-09-09 Other acquisition +7,391 7,391 D
Bolzon Bradley J PhD Director 2020-09-10 Sale −14,161 $85.03 $1,204,066 540,029 I
Bolzon Bradley J PhD Director 2020-09-10 Sale −8,684 $85.90 $745,930 531,345 I
Open-market sales · 22,845 sh · avg $85.36 · $1,949,996
Loading xslF345X03/doc4.xml…